Incorporating Parp-inhibitors in Primary and Recurrent Ovarian Cancer: A Meta-analysis of 12 phase II/III randomized controlled trials
Ilary Ruscito, Filippo Bellati, Isabelle Ray‐Coquard, Mansoor Raza Mirza, Andreas du Bois, Maria Luisa Gasparri, Flavia Costanzi, Maria Paola De Marco, Marianna Nuti, Donatella Caserta, Sandro Pignata, Oliver Dorigo, Jalid Sehouli, Elena Ioana Braicu
Topics & Concepts
MedicineInternal medicineOncologyBevacizumabOvarian cancerCancerRandomized controlled trialPARP inhibitorAnemiaChemotherapyGastroenterologyPoly ADP ribose polymerasePolymeraseBiochemistryChemistryGenePARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentAdvanced Breast Cancer Therapies